TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
DCTH

Delcath Systems Inc

Healthcare · Medical Devices

16.30$ +0.2% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Delcath Systems Inc (DCTH)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 82.9% of the shares are freely tradable; institutional investors hold 48.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 48.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 8.1%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 82.9%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 7.0%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 35Mio.

Largest Shareholders

Institutions

Institutions DCTH
Name Stake (%) Shares Change (%) Date
Rosalind Advisors, Inc. 9.51 3,300,389 +0.0 03/31/2026
BlackRock Inc 5.14 1,784,466 -2.2 03/31/2026
Vanguard Capital Management, LLC 3.83 1,329,288 +0.0 03/31/2026
Propel Bio Management LLC 2.51 871,460 -11.0 06/30/2026
Geode Capital Management, LLC 1.99 692,031 +1.3 03/31/2026
State Street Corp 1.91 664,428 +9.3 03/31/2026
Algert Global LLC 1.67 580,708 +298.5 06/30/2026
Millennium Management LLC 1.63 566,371 -3.7 06/30/2026

Funds

Funds DCTH
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.56 889,410 +0.0 07/31/2026
iShares Russell 2000 ETF 2.15 745,825 -0.6 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?